The evidence for involvement of type C RNA tumor viruses in human acute leukemia

Mucosal mast cells are indispensable for the timely termination of Strongyloides ratti infection.

Mucosal immunology·2016

A nine-gene signature predicting clinical outcome in cutaneous melanoma.

Journal of cancer research and clinical oncology·2012

How to deal with incompletely treated AVMs: experience of 67 cases and review of the literature.

Acta neurochirurgica. Supplement·2011

Excitatory and inhibitory purinergic control of neck muscle nociception in anaesthetized mice.

Cephalalgia : an international journal of headache·2009

Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients.

British journal of cancer·2007

Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN).

British journal of cancer·2006

Dynamic changes of claudin 18.2 expression after systemic therapy in gastric and esophagogastric junction cancer.

Cancer·2026

Perioperative immunotherapy in head and neck squamous cell carcinoma.

Cancer·2026

Redefining leptomeningeal metastasis in non-small cell lung cancer: From terminal complication to molecularly managed disease.

Cancer·2026

Targeting RAS in pancreatic cancer.

Cancer·2026

Phase 1 dose escalation and expansion trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein SL-172154 (SIRPα-Fc-CD40L) in patients with higher-risk myelodysplastic syndrome or acute myeloid leukemia.

Cancer·2026

Current challenges and emerging therapeutic strategies in lung cancer care: Insights from Bridging the Gaps 2025.

Cancer·2026

Exploring the Expanding Role of Nuclear Receptor LRH-1/NR5A2 in Cell Biology and Immunity.

International journal of cell biology·2026

Cuproptosis-related molecular alterations in a neonatal rat model of hypoxic-ischemic brain damage.

Frontiers in neurology·2026

Off-Target MAP2K7 Inhibition Drives the Antileukemic Activity of the PD-1/PD-L1 inhibitor ACS-69 in Pediatric T-ALL.

Research square·2026

A CRISPR-Cas9 platform for primary human hepatocytes enables arrayed screening and in vivo validation of HBV host factors.

bioRxiv : the preprint server for biology·2026

Myeloid differentiation-associated autophagy drives venetoclax resistance in AML.

Research square·2026

Structure of full-length APOBEC3B bound to EBV BORF2 reveals coordinated neutralization of a cancer-associated mutator.

Research square·2026

Related Experiment Videos

The evidence for involvement of type C RNA tumor viruses in human acute leukemia

Related Concept Videos

Mucosal mast cells are indispensable for the timely termination of Strongyloides ratti infection.

A nine-gene signature predicting clinical outcome in cutaneous melanoma.

How to deal with incompletely treated AVMs: experience of 67 cases and review of the literature.

Excitatory and inhibitory purinergic control of neck muscle nociception in anaesthetized mice.

Cisplatin, gemcitabine, and treosulfan in relapsed stage IV cutaneous malignant melanoma patients.

Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN).

Dynamic changes of claudin 18.2 expression after systemic therapy in gastric and esophagogastric junction cancer.

Perioperative immunotherapy in head and neck squamous cell carcinoma.

Redefining leptomeningeal metastasis in non-small cell lung cancer: From terminal complication to molecularly managed disease.

Targeting RAS in pancreatic cancer.

Phase 1 dose escalation and expansion trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein SL-172154 (SIRPα-Fc-CD40L) in patients with higher-risk myelodysplastic syndrome or acute myeloid leukemia.

Current challenges and emerging therapeutic strategies in lung cancer care: Insights from Bridging the Gaps 2025.

Exploring the Expanding Role of Nuclear Receptor LRH-1/NR5A2 in Cell Biology and Immunity.

Cuproptosis-related molecular alterations in a neonatal rat model of hypoxic-ischemic brain damage.

Off-Target MAP2K7 Inhibition Drives the Antileukemic Activity of the PD-1/PD-L1 inhibitor ACS-69 in Pediatric T-ALL.

A CRISPR-Cas9 platform for primary human hepatocytes enables arrayed screening and in vivo validation of HBV host factors.

Myeloid differentiation-associated autophagy drives venetoclax resistance in AML.

Structure of full-length APOBEC3B bound to EBV BORF2 reveals coordinated neutralization of a cancer-associated mutator.

Related Experiment Videos

The evidence for involvement of type C RNA tumor viruses in human acute leukemia

Related Concept Videos

Related Articles